Ocular Therapeutix

Driven by a vision

Pioneering a new era of drug delivery in ophthalmology

Ocular Therapeutix is a biopharmaceutical company aspiring to be a leader in ophthalmology by leveraging its proprietary hydrogel technology to develop transformational drug products that enhance the patient and provider experience.

Featured Press Release

FDA Accepts DEXTENZA NDA Submission
Action Date: Dec. 28, 2018